Detects 200 selected variants in the CFTR gene associated with cystic fibrosis.
Used for cystic fibrosis carrier screening and as a first-line molecular test when cystic fibrosis is clinically suspected. Because this is a targeted panel, a negative result does not exclude every disease-causing CFTR variant.